Another UFC fighter has been suspended because of a tainted supplement. According to the UFC-funded Combat Sports Anti-Doping (CSAD) agency, ranked strawweight contender Jaqueline Amorim has failed two out-of-competition drug tests on July 29 and August 17, 2026 due to Ostarine being in her system.
The two tests will fall under one violation, and Amorim will be subject to a shorter six month suspension as they have determined the failure to be due to a supplement.
“During CSAD’s investigation, Amorim provided full and complete cooperation as defined under the UFC ADP. After reviewing the evidence, CSAD determined that the findings were consistent with exposure to low-level ostarine contamination rather than intentional use,” the official statement declared.
“This determination was based on several factors, including Amorim’ testing history, the low levels of ostarine detected in both samples, her use of multiple dietary supplements that had not been third-party tested and certified, and the documented prevalence of ostarine contamination in dietary supplements worldwide. The evidence also did not indicate that Amorim’ exposure provided her with any significant performance advantage.”
Amorim’s suspension will retroactively begin from the second test on August 17, 2026, which will make her eligible to compete on February 17, 2027.
Amorim, 31, is currently 5-2 in the UFC, and is coming off a first-round armbar win over Loma Lookboonmee last May.